These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2177206)

  • 1. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
    Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ
    J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M; Kazama T; Ikeda T; Sato S
    Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients.
    Kafka MS; Kleinman JE; Karson CN; Wyatt RJ
    Hillside J Clin Psychiatry; 1986; 8(1):15-24. PubMed ID: 3017834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-tocopherol on platelet membrane function in cystic fibrosis.
    Davis PB; Hubbard VS; Dieckman L; Boat TF; Stern RC; Doershuk CF
    J Lab Clin Med; 1984 Aug; 104(2):203-12. PubMed ID: 6086795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 suppression of platelet aggregation response in schizophrenia.
    Kaiya H
    Schizophr Res; 1991; 5(1):67-80. PubMed ID: 1854678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin receptor sensitivity in psychiatric disorders.
    Kanof PD; Johns C; Davidson M; Siever LJ; Coccaro EF; Davis KL
    Arch Gen Psychiatry; 1986 Oct; 43(10):987-93. PubMed ID: 3019269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.